Royalty Pharma Receives Target Price Boost from Morgan Stanley, Showing Promising Growth Potential in the Biopharmaceutical Sector
On October 11, 2023, Royalty Pharma (NASDAQ: RPRX) received a boost in its target price from renowned stock analysts at ...